Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=28481368
&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests
in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215
Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 245.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 245.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 245.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 245.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 245.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 245.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 245.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 278.79999999999995 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 278.79999999999995 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Warning: imagejpeg(C:\Inetpub\vhosts\kidney.de\httpdocs\phplern\28481368
.jpg): Failed to open stream: No such file or directory in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 117 Oncogenesis
2017 ; 6
(5
): e328
Nephropedia Template TP
gab.com Text
Twit Text FOAVip
Twit Text #
English Wikipedia
Regulation of miR-483-3p by the O-linked N-acetylglucosamine transferase links
chemosensitivity to glucose metabolism in liver cancer cells
#MMPMID28481368
Pepe F
; Pagotto S
; Soliman S
; Rossi C
; Lanuti P
; Braconi C
; Mariani-Costantini R
; Visone R
; Veronese A
Oncogenesis
2017[May]; 6
(5
): e328
PMID28481368
show ga
The miR-483-3p is upregulated in several tumors, including liver tumors, where it
inhibits TP53-dependent apoptosis by targeting the pro-apoptotic gene BBC3/PUMA.
The transcriptional regulation of the miR-483-3p could be driven by the
?-catenin/USF1 complex, independently from its host gene IGF2, and we previously
demonstrated that in HepG2 hepatoblastoma cells carrying wild-type TP53 the
upregulation of the miR-483-3p overcomes the antitumoral effects of the
tumor-suppressor miR-145-5p by a mechanism involving cellular glucose
availability. Here we demonstrate that in HepG2 cells, the molecular link between
glucose concentration and miR-483-3p expression entails the O-linked
N-acetylglucosamine (O-GlcNAc) transferase (OGT), which stabilizes the
transcriptional complex at the miR-483 promoter. HepG2 cells showed reduced
miR-483-3p expression and increased susceptibility to 5-fluorouracil
(5-FU)-induced apoptosis in presence of the inhibitor of glycolysis
2-deoxy-d-glucose (2-DG). However, in vivo experiments showed that HepG2 cells
with higher miR-483-3p expression were selected during tumor progression
regardless of 5-FU treatment. Furthermore, treatment with 2-DG alone did not
significantly reduce HepG2 xenograft load in immunodeficient mice. In conclusion,
we show that in HepG2 cells glucose uptake increases the expression of the
oncogenic miR-483-3p through the OGT pathway. This suggests that depletion of the
miR-483-3p may be a valuable therapeutic approach in liver cancer patients, but
the use of inhibitors of glycolysis to achieve this purpose could accelerate the
selection of resistant neoplastic cell clones.